Cardiff Oncology (CRDF) Other Non-Current Assets (2011 - 2026)

Cardiff Oncology has reported Other Non-Current Assets for 15 years, with the latest figure at $549000.0 in Q4 2025.

• Quarterly Other Non-Current Assets rose 695.65% year-over-year to $549000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $549000.0 (up 695.65% YoY) and the FY2025 annual result came in at $549000.0, up 695.65% from the prior year.
• Other Non-Current Assets was little changed at $549000.0 in Q4 2025 per CRDF's latest filing, from $549000.0 in the prior quarter.
• Over five years, Other Non-Current Assets peaked at $1.4 million in Q2 2023 and troughed at $69000.0 in Q4 2024.
• A 5-year average of $694100.0 and a median of $475000.0 in 2025 frame the typical range for Other Non-Current Assets.
• The sharpest annual moves came in 2024 and 2025: Other Non-Current Assets sank 94.61% in 2024, then surged 695.65% in 2025.
• Over 5 years, Other Non-Current Assets stood at $239000.0 in 2021, then surged by 480.33% to $1.4 million in 2022, then fell by 7.79% to $1.3 million in 2023, then tumbled by 94.61% to $69000.0 in 2024, then soared by 695.65% to $549000.0 in 2025.
• According to Business Quant data, Other Non-Current Assets over the past three periods registered $549000.0, $549000.0, and $401000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.